Mapeamento De Temáticas E Elementos De Validação Científica Nos Artigos Sobre COVID-19 José Carlos Miranda Barbosa

Total Page:16

File Type:pdf, Size:1020Kb

Mapeamento De Temáticas E Elementos De Validação Científica Nos Artigos Sobre COVID-19 José Carlos Miranda Barbosa 2.ºCiclo Ciências da Comunicação – Cultura e Ciência Comunicar em tempos de pandemia: Mapeamento de temáticas e elementos de validação científica nos artigos sobre COVID-19 José Carlos Miranda Barbosa M 2020 José Carlos Miranda Barbosa Comunicar em tempos de pandemia: Mapeamento de temáticas e elementos de validação científica nos artigos sobre COVID-19 Dissertação realizada no âmbito do Mestrado em Ciências da Comunicação, orientada pela Professora Doutora Helena Lima Faculdade de Letras da Universidade do Porto outubro de 2020 Comunicar em tempos de pandemia: Mapeamento de temáticas e elementos de validação científica nos artigos sobre COVID-19 José Carlos Miranda Barbosa Dissertação realizada no âmbito do Mestrado em Ciências da Comunicação, orientada pela Professora Doutora Helena Lima Membros do Júri Professor Doutor …. Faculdade …. - Universidade ... Professor Doutor …. Faculdade …. - Universidade … Professor Doutor …. Faculdade …. - Universidade ... Classificação obtida: …. valores Ao meu falecido bisavô que sempre teve o sonho de me ver “formado” Sumário Declaração de honra ................................................................................................................... 10 Agradecimentos .......................................................................................................................... 11 Resumo ........................................................................................................................................ 13 Abstract ....................................................................................................................................... 14 Índice de Figuras ......................................................................................................................... 15 Índice de tabelas/diagramas ....................................................................................................... 16 Índice de Gráficos ........................................................................................................................ 17 Lista de abreviaturas e siglas ....................................................................................................... 18 Glossário ...................................................................................................................................... 19 Introdução ................................................................................................................................... 21 Capítulo 1 – Processos Comunicacionais e Comunidade Científica ............................................ 24 1.1. Comunidade científica como ponto de partida para o conceito de comunicação científica ................................................................................................................................................. 24 1.1.1. Comunidade Científica ..…………….…………………………………………………………………... 24 1.1.2. Comunicação Científica ..………………………………………………………………………………... 28 1.1.3. A evolução do sistema de comunicação científica ………………………………………….. 30 1.2. Da comunicação científica tradicional à eletrónica ......................................................... 34 1.2.1. Comunicação Científica tradicional ………………………………………………………………… 34 1.2.2. Comunicação Científica eletrónica ….……………………………………………………………… 35 1.3. Uma área em desenvolvimento: A abrangência da Comunicação de Saúde ................... 38 1.4. A Literacia em Saúde como promoção de uma boa comunicação .................................. 39 1.5. Breve contexto da COVID-19 ............................................................................................ 41 Capítulo 2. – Metodologia ........................................................................................................... 43 2.1. Breve abordagem sobre Revisão Sistemática .................................................................. 43 2.2. Elaboração de uma Revisão Sistemática .......................................................................... 46 2.2.1. Vantagens e desvantagens …………………………………………………………………………….. 46 2.2.2. Etapas de uma Revisão Sistemática ……………………………………………………………….. 48 8 2.3. Descrição da metodologia utilizada: A Revisão Sistemática de publicações científicas sobre a COVID-19 .................................................................................................................... 52 Capítulo 3. – Revisão Sistemática ................................................................................................ 55 3.1. Descrição da Amostra ...................................................................................................... 55 3.2. Análise dos dados ............................................................................................................. 56 3.3. Discussão .......................................................................................................................... 65 Considerações finais .................................................................................................................... 70 Referências bibliográficas ........................................................................................................... 72 Anexos ......................................................................................................................................... 78 Anexo 1 .................................................................................................................................... 79 Tabela de Revisão Sistemática de publicações científicas ...................................................... 79 Anexo 2 .................................................................................................................................. 117 Lista de referências bibliográficas recolhidas de 20 de novembro de 2019 a 2 de abril de 2020 (excluindo as que estavam em duplicado) .................................................................. 117 9 Declaração de honra Declaro que a presente dissertação é de minha autoria e não foi utilizado previamente noutro curso ou unidade curricular, desta ou de outra instituição. As referências a outros autores (afirmações, ideias, pensamentos) respeitam escrupulosamente as regras da atribuição, e encontram-se devidamente indicadas no texto e nas referências bibliográficas, de acordo com as normas de referenciação. Tenho consciência de que a prática de plágio e auto-plágio constitui um ilícito académico. [Porto, 19 de outubro de 2020] [José Carlos Miranda Barbosa] 10 Agradecimentos Num processo como este que é realizar uma dissertação, existem tantas pessoas que merecem ter um lugar de destaque, por mais pequeno que seja, nesta página. As pessoas a quem irei agradecer estiveram sempre ao meu lado a incentivar-me, a apoiar- me, a perguntar se precisava de ajuda. Numa situação extraordinária como aquela que vivemos atualmente aprendi a dar ainda mais valor aos que tenho a meu lado. Em primeiro lugar queria agradecer à minha família, aos meus pais, aos meus avós, aos meus tios, aos meus primos, à minha afilhada, à minha irmã, sem eles nunca teria chegado a esta etapa da minha vida. Um especial obrigado à minha Mãe que, por não ter seguido o seu sonho, quis ver o seu filho a seguir o dele e não há nada que me deixe mais feliz do que a ver orgulhosa de mim. Aos meus amigos, ao Leonardo, à Manuela, ao Curveira, ao Seixo, à Cátia, a todas as raparigas do meu ano a quem carinhosamente chamo de “as minhas meninas” que estão a meu lado desde o primeiro ano de faculdade, que viveram comigo aventuras e desventuras de uma vida académica e não só. Um especial obrigado à Ivone que, após 16 anos de amizade, continua a meu lado. A ela que me ajudou incansavelmente na Revisão Sistemática, que me ajudou nas dúvidas que tive construção da tabela, na opinião quanto à verificação dos dados, dentro de muitas outras coisas, obrigado, de coração, a esta amiga que será a minha futura contabilista. Agradeço ao Professor Doutor Vasco Ribeiro, aquele que foi o meu primeiro orientador, que acompanhou todas as mudanças, desde o Estágio que iria fazer e acabou por não se concretizar, na procura de um novo Estágio e na mudança para Dissertação. Obrigado por me ter aconselhado e apoiado em todas as minhas decisões. Agradeço ainda à Equipa BRIGHT, pessoas que me acolheram no Estágio Curricular, que às 9 horas da manhã estavam com um excelente humor para me ajudar nas minhas dificuldades. Agradeço em especial ao Hernâni Zão Oliveira, Fouder & CEO da BRIGHT, que presencialmente ou à distância sempre acreditou e confiou em mim, uma pessoa que passei a admirar. Devo-lhe a ele a solução arranjada de passar a realizar esta 11 Dissertação em vez de um Relatório de Estágio que, devido à pandemia, iria condicionar o conteúdo. Agradeço, de coração, por me acolherem e por ter tido a oportunidade de fazer parte desta equipa. Por último e à pessoa mais importante, a Professora Doutora Helena Lima, minha orientadora. Com todas as complicações que surgiram no meu caminho de mudanças de Estágio e, posteriormente, para dissertação, foi a Professora Helena Lima que me passou a acolher. Em maio, quando pedi à Professora para passar a ser a minha orientadora, sem hesitar, ela aceitou e eu fiquei muito feliz por tê-la a orientar-me neste projeto. A conclusão deste trabalho deve-se a ela, deve-se a todas as dúvidas que me tirou, a todos os caminhos que me ajudou a encontrar, a todas as reuniões realizadas. Agradeço por estar sempre disponível e disposta a ajudar. Agradeço à Professora pelo apoio e peço desculpa por todas
Recommended publications
  • The 49Th Annual Meeting of the Japanese Society for Immunology
    http://icongroup.co.jp/49immunology/ The 49th Annual Meeting of the Japanese Society for Immunology December 8, 2020-Online Meeting P r e s i d e n t: Hiroshi Kiyono, President and Chairman of Board, JSI COVID-19 and Immunity Keynote Remarks Registration Anthony S. Fauci, Director of NIAID, U.S.A. http://icongroup.co.jp/49immunology/ November 2 (Noon - JST) Symposium Early -November 30 (Noon - JST) Vaccine and Immunity * Credit card or Bank transfer December 1 (Noon - JST) Akiko Iwasaki, Yale University, U.S.A. Late -December 25 (Noon - JST) Alessandro Sette, La Jolla Institute for Immunology, U.S.A. * Credit card only George Fu Gao, China CDC, China Regular Member: 1,000JPY, Student Member: Free Hironori Nakagami, Osaka University, Japan Non-member: 2,000JPY, Student Non-member: 500JPY Ken J Ishii, The University Tokyo, Japan Cytokine Storm and Related Disease ■Steering committee & Program Committee Tadamitsu Kishimoto, Osaka University, Japan Chair: Toshiaki Ohteki, Tokyo Medical and Dental University Josef Penninger, University of British Columbia, Canada Members: Miyuki Azuma, Tokyo Medical and Dental University Yumiko Imai, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Japan Tsuneyasu Kaisho, Wakayama Medical University Takanori Kanai, Keio University, Japan Hiroshi Kawamoto, Kyoto University Hisashi Arase, Osaka University, Japan Noriko Sorimachi, National Center for Global Health and Medicine Kiyoshi Takeda, Osaka University Shohei Hori, The University of Tokyo Review Talk (in Japanese) Koji Yasutomo,
    [Show full text]
  • Hong Kong SAR
    China Data Supplement November 2006 J People’s Republic of China J Hong Kong SAR J Macau SAR J Taiwan ISSN 0943-7533 China aktuell Data Supplement – PRC, Hong Kong SAR, Macau SAR, Taiwan 1 Contents The Main National Leadership of the PRC 2 LIU Jen-Kai The Main Provincial Leadership of the PRC 30 LIU Jen-Kai Data on Changes in PRC Main Leadership 37 LIU Jen-Kai PRC Agreements with Foreign Countries 47 LIU Jen-Kai PRC Laws and Regulations 50 LIU Jen-Kai Hong Kong SAR 54 Political, Social and Economic Data LIU Jen-Kai Macau SAR 61 Political, Social and Economic Data LIU Jen-Kai Taiwan 65 Political, Social and Economic Data LIU Jen-Kai ISSN 0943-7533 All information given here is derived from generally accessible sources. Publisher/Distributor: GIGA Institute of Asian Affairs Rothenbaumchaussee 32 20148 Hamburg Germany Phone: +49 (0 40) 42 88 74-0 Fax: +49 (040) 4107945 2 November 2006 The Main National Leadership of the PRC LIU Jen-Kai Abbreviations and Explanatory Notes CCP CC Chinese Communist Party Central Committee CCa Central Committee, alternate member CCm Central Committee, member CCSm Central Committee Secretariat, member PBa Politburo, alternate member PBm Politburo, member Cdr. Commander Chp. Chairperson CPPCC Chinese People’s Political Consultative Conference CYL Communist Youth League Dep. P.C. Deputy Political Commissar Dir. Director exec. executive f female Gen.Man. General Manager Gen.Sec. General Secretary Hon.Chp. Honorary Chairperson H.V.-Chp. Honorary Vice-Chairperson MPC Municipal People’s Congress NPC National People’s Congress PCC Political Consultative Conference PLA People’s Liberation Army Pol.Com.
    [Show full text]
  • July 2020 Strategies for Emerging Infectious Diseases
    THE AMERICAN WWW.CAYMANCHEM.COM ASSOCIATION OF IMMUNOLOGISTS AT ISSUE NEW THE DOWNLOAD Virus Life Cycle Infographic Infographic Cycle Life Virus JULY 2020 Resources for Your Research Your for Resources Informative Articles Informative CAYMAN CURRENTS: CAYMAN IN THIS ISSUE OF THE THE OF ISSUE THIS IN DISEASES INFECTIOUS EMERGING AAI Looks Back: How Honolulu’s Chinatown FOR STRATEGIES "Went Up in Smoke" A history of the first plague outbreak in Hawai’i, page 30 ANTIVIRAL 28 No. Permit CAYMAN CURRENTS PA Gettysburg, PAID 20852 20852 20852 20852 MD MD MD MD Rockville, Rockville, Rockville, Rockville, 650, 650, 650, 650, Suite Suite Suite Suite Pike, Pike, Pike, Pike, Rockville Rockville Rockville Rockville 1451 1451 1451 1451 Postage U.S. Non-Proft Org. Non-Proft IMMUNOLOGISTS IMMUNOLOGISTS IMMUNOLOGISTS IMMUNOLOGISTS OF OF OF OF ASSOCIATION ASSOCIATION ASSOCIATION ASSOCIATION AMERICAN AMERICAN AMERICAN AMERICAN THE THE THE THE 2020 advanced Course in Immunology Now Virtual! I July 26–31, 2020 IN THIS ISSUE Director: Wayne M. Yokoyama, M.D. Washington University School of Medicine in St. Louis x4 Executive Offce The American Association Don’t miss the premier course in immunology for research scientists! of Immunologists x8 Public Affairs This intensive course is directed toward advanced trainees and scientists who wish to expand or update 1451 Rockville Pike, Suite 650 their understanding of the feld. Leading experts will present recent advances in the biology of the Rockville, MD 20852 20 Members in the News immune system and address its role in health and disease. This is not an introductory course; Tel: 301-634-7178 attendees will need to have a frm understanding of the principles of immunology.
    [Show full text]
  • International Symposium on Novel Ideas in Science and Ethics Of
    I N T E R N A T I O N A L S Y M P O S I U M O N N O V E L I D E A S I N S C I E N C E A N D E T H I C S O F V A C C I N E S A G A I N S T C O V I D - 1 9 P A N D E M I C 30 JULY 2020 DEPARTMENT OF HEALTH RESEARCH MINISTRY OF HEALTH AND FAMILY WELFARE, GOVERNMENT OF INDIA International Symposium on Novel ideas in Science and Ethics of Vaccines against COVID-19 pandemic Date: 30th July 2020 / 4:30 pm – 6:45 pm IST (A fully online, multi-country program) Moderated / Facilitated by Chris Anderson, Curator, TED talks Follow Live at - https://icmrvaccines.impcom.in/ Timing (IST) Session Speakers / Discussants Prof K VijayRaghavan Principal Scientific Advisor to Govt. of India Dr Renu Swarup Secretary, Dept of Biotechnology, Government of India 16.30 – 16:36 Welcome and Introductory Statement Prof Heidi Larson Director of The Vaccine Confidence Project (VCP); Professor, London School of Hygiene and Tropical Medicine, UK Prof Adam Kamradt-Scott Director, Global Health Security Network, Associate Professor, University of Sydney, Australia 16:36 – 16:41 Confronting the pandemic Dr Anthony S Fauci Director, National Institute of Allergy and Infectious Diseases, USA 16:42 – 16:43 A short Video Timely & Safe – Towards a Covid-19 Prof Peter Piot vaccine (Leadership remarks)- Role of Director, London School of Hygiene and Tropical Medicine, UK vaccines in ending epidemics Prof Stanley Plotkin 16:45 – 17:06 Introduced by: Mr JVR Prasada Rao Author of Plotkin’s Vaccines, Emeritus Professor, University of Pennsylvania, USA National Task Force COVID-19 member and Former Secretary for Health, Govt.
    [Show full text]
  • Recent Articles from the China Journal of System Engineering Prepared
    Recent Articles from the China Journal of System Engineering Prepared by the University of Washington Quantum System Engineering (QSE) Group.1 Bibliography [1] Mu A-Hua, Zhou Shao-Lei, and Yu Xiao-Li. Research on fast self-adaptive genetic algorithm and its simulation. Journal of System Simulation, 16(1):122 – 5, 2004. [2] Guan Ai-Jie, Yu Da-Tai, Wang Yun-Ji, An Yue-Sheng, and Lan Rong-Qin. Simulation of recon-sat reconing process and evaluation of reconing effect. Journal of System Simulation, 16(10):2261 – 3, 2004. [3] Hao Ai-Min, Pang Guo-Feng, and Ji Yu-Chun. Study and implementation for fidelity of air roaming system above the virtual mount qomolangma. Journal of System Simulation, 12(4):356 – 9, 2000. [4] Sui Ai-Na, Wu Wei, and Zhao Qin-Ping. The analysis of the theory and technology on virtual assembly and virtual prototype. Journal of System Simulation, 12(4):386 – 8, 2000. [5] Xu An, Fan Xiu-Min, Hong Xin, Cheng Jian, and Huang Wei-Dong. Research and development on interactive simulation system for astronauts walking in the outer space. Journal of System Simulation, 16(9):1953 – 6, Sept. 2004. [6] Zhang An and Zhang Yao-Zhong. Study on effectiveness top analysis of group air-to-ground aviation weapon system. Journal of System Simulation, 14(9):1225 – 8, Sept. 2002. [7] Zhang An, He Sheng-Qiang, and Lv Ming-Qiang. Modeling simulation of group air-to-ground attack-defense confrontation system. Journal of System Simulation, 16(6):1245 – 8, 2004. [8] Wu An-Bo, Wang Jian-Hua, Geng Ying-San, and Wang Xiao-Feng.
    [Show full text]
  • San Bernardino County Waiting, for Now, to Expand Stage 2 Coronavirus Reopening – Redlands Daily Facts
    San Bernardino County waiting, for now, to expand Stage 2 coronavirus reopening – Redlands Daily Facts LOCAL NEWS • News San Bernardino County waiting, for now, to expand Stage 2 coronavirus reopening By SANDRA EMERSON | [email protected] | PUBLISHED: May 19, 2020 at 4:58 p.m. | UPDATED: May 19, 2020 at 10:37 p.m. While San Bernardino County supervisors are eager for restaurants and churches to resume operations after weeks of novel coronavirus-related closures and restrictions, they’re waiting to see how the county’s data pairs with new state guidelines on reopening various sectors. After a lively debate Tuesday, May 19, about the risks associated with reopening ahead of the state, the supervisors agreed to hear more from county staff before expanding the second of the state’s four-phase plan to reopen businesses. Supervisors agreed to meet at 4 p.m. Thursday, May 21, to further discuss the matter. “Our small businesses have sat and waited,” Supervisor Robert Lovingood said. “They’ve waited patiently as long as they can. They cannot suffer this economic suppression any longer.” Lovingood and Supervisor Dawn Rowe supported moving forward with the county’s recovery plan, which assesses the risk of the virus’ spread at businesses and offers guidelines for reopening safely. However, the item was not on the agenda, so the board agreed to schedule a special meeting. https://www.redlandsdailyfacts.com/2020/05/19/san-bernardino-county-waiting-for-now-to-expand-stage-2-coronavirus-reopening/[5/20/2020 8:18:00 AM] San Bernardino County waiting, for now, to expand Stage 2 coronavirus reopening – Redlands Daily Facts TOP ARTICLES 1/5 S A By .st0{fill:#FFFFFF;}.st1{fill:#0099FF;} M READ MORE Thousands evacuated as river dams break in central “This is a serious thing we have to do in the right way,” Chairman Curt Hagman said.
    [Show full text]
  • Journal of Current Chinese Affairs
    3/2006 Data Supplement PR China Hong Kong SAR Macau SAR Taiwan CHINA aktuell Journal of Current Chinese Affairs Data Supplement People’s Republic of China, Hong Kong SAR, Macau SAR, Taiwan ISSN 0943-7533 All information given here is derived from generally accessible sources. Publisher/Distributor: Institute of Asian Affairs Rothenbaumchaussee 32 20148 Hamburg Germany Phone: (0 40) 42 88 74-0 Fax:(040)4107945 Contributors: Uwe Kotzel Dr. Liu Jen-Kai Christine Reinking Dr. Günter Schucher Dr. Margot Schüller Contents The Main National Leadership of the PRC LIU JEN-KAI 3 The Main Provincial Leadership of the PRC LIU JEN-KAI 22 Data on Changes in PRC Main Leadership LIU JEN-KAI 27 PRC Agreements with Foreign Countries LIU JEN-KAI 30 PRC Laws and Regulations LIU JEN-KAI 34 Hong Kong SAR Political Data LIU JEN-KAI 36 Macau SAR Political Data LIU JEN-KAI 39 Taiwan Political Data LIU JEN-KAI 41 Bibliography of Articles on the PRC, Hong Kong SAR, Macau SAR, and on Taiwan UWE KOTZEL / LIU JEN-KAI / CHRISTINE REINKING / GÜNTER SCHUCHER 43 CHINA aktuell Data Supplement - 3 - 3/2006 Dep.Dir.: CHINESE COMMUNIST Li Jianhua 03/07 PARTY Li Zhiyong 05/07 The Main National Ouyang Song 05/08 Shen Yueyue (f) CCa 03/01 Leadership of the Sun Xiaoqun 00/08 Wang Dongming 02/10 CCP CC General Secretary Zhang Bolin (exec.) 98/03 PRC Hu Jintao 02/11 Zhao Hongzhu (exec.) 00/10 Zhao Zongnai 00/10 Liu Jen-Kai POLITBURO Sec.-Gen.: Li Zhiyong 01/03 Standing Committee Members Propaganda (Publicity) Department Hu Jintao 92/10 Dir.: Liu Yunshan PBm CCSm 02/10 Huang Ju 02/11
    [Show full text]
  • Behind the Mask
    BEHIND THE MASK: Determinants of Nurses’ Adherence to Recommended Use of Facial Protective Equipment to Prevent Occupational Transmission of Communicable Respiratory Illness in Acute Care Hospitals by Kathryn Anne Nichol A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Institute of Medical Science University of Toronto © Copyright by Kathryn Anne Nichol (2010) BEHIND THE MASK: Determinants of Nurses’ Adherence to Recommended Use of Facial Protective Equipment to Prevent Occupational Transmission of Communicable Respiratory Illness in Acute Care Hospitals Kathryn Anne Nichol Doctor of Philosophy Institute of Medical Science University of Toronto 2010 Abstract (max 350w) Background - Communicable respiratory illness is a serious occupational threat to healthcare workers. A key reason for occupational transmission is failure to implement appropriate barrier precautions. Facial protective equipment, including surgical masks, respirators and eye/face protection, is the least adhered to type of personal protective equipment used by healthcare workers, yet it is an important barrier precaution against communicable respiratory illness. Objectives - To describe nurses‘ adherence to recommended use of facial protective equipment and to identify the factors that influence adherence. Methods - A two-phased study was conducted. Phase 1 was a cross-sectional survey of nurses in selected units of six acute care hospitals in Toronto, Canada. Phase 2 was a direct observational study of critical care nurses. ii Results – Of the 1074 nurses who completed surveys (82% response rate), 44% reported adherence to recommended use of facial protective equipment. Multivariable analysis revealed four organizational predictors of adherence: ready availability of equipment, regular training and fit testing, organizational support for health and safety, and good communication.
    [Show full text]
  • Life, Thought and Image of Wang Zheng, a Confucian-Christian in Late Ming China
    Life, Thought and Image of Wang Zheng, a Confucian-Christian in Late Ming China Inaugural-Dissertation zur Erlangung der Doktorwürde der Philosophischen Fakultät der Rheinischen Friedrich-Wilhelms-Universität zu Bonn vorgelegt von Ruizhong Ding aus Qishan, VR. China Bonn, 2019 Gedruckt mit der Genehmigung der Philosophischen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn Zusammensetzung der Prüfungskommission: Prof. Dr. Dr. Manfred Hutter, Institut für Orient- und Asienwissenschaften (Vorsitzender) Prof. Dr. Wolfgang Kubin, Institut für Orient- und Asienwissenschaften (Betreuer und Gutachter) Prof. Dr. Ralph Kauz, Institut für Orient- und Asienwissenschaften (Gutachter) Prof. Dr. Veronika Veit, Institut für Orient- und Asienwissenschaften (weiteres prüfungsberechtigtes Mitglied) Tag der mündlichen Prüfung:22.07.2019 Acknowledgements Currently, when this dissertation is finished, I look out of the window with joyfulness and I would like to express many words to all of you who helped me. Prof. Wolfgang Kubin accepted me as his Ph.D student and in these years he warmly helped me a lot, not only with my research but also with my life. In every meeting, I am impressed by his personality and erudition deeply. I remember one time in his seminar he pointed out my minor errors in the speech paper frankly and patiently. I am indulged in his beautiful German and brilliant poetry. His translations are full of insightful wisdom. Every time when I meet him, I hope it is a long time. I am so grateful that Prof. Ralph Kauz in the past years gave me unlimited help. In his seminars, his academic methods and sights opened my horizons. Usually, he supported and encouraged me to study more fields of research.
    [Show full text]
  • 1. Sars-Cov Nucleocapsid Protein Epitopes and Uses Thereof
    www.engineeringvillage.com Citation results: 500 Downloaded: 4/24/2020 1. SARS-COV NUCLEOCAPSID PROTEIN EPITOPES AND USES THEREOF KELVIN, David; PERSAD, Desmond; CAMERON, Cheryl; BRAY, Kurtis, R.; LOFARO, Lori, R.; JOHNSON, Camille; SEKALY, Rafick-Pierre; YOUNES, Souheil-Antoine; CHONG, Pele Assignee: UNIVERSITY HEALTH NETWORK; BECKMAN COULTER, INC.; UNIVERSITE DE MONTREAL; NATIONAL HEALTH RESEARCH INSTITUTES Publication Number: WO2005103259 Publication date: 11/03/2005 Kind: Patent Application Publication Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 2. SARS-CoV-specific B-cell epitope and applications thereof Wu, Han-Chung; Liu, I-Ju; Chiu, Chien-Yu Assignee: National Taiwan University Publication Number: US20060062804 Publication date: 03/23/2006 Kind: Utility Patent Application Database: US Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 3. A RECOMBINANT SARS-COV VACCINE COMPRISING ATTENUATED VACCINIA VIRUS CARRIERS QIN, Chuan; WEI, Qiang; GAO, Hong; TU, Xinming; CHEN, Zhiwei; ZHANG, Linqi; HO, David, D. Assignee: INSTITUTE OF LABORATORY ANIMAL SCIENCE OF CHINESE ACADEMY OF MEDICAL SCIENCES; THE AARON DIAMOND AIDS RESEARCH CENTER; QIN, Chuan; WEI, Qiang; GAO, Hong; TU, Xinming; CHEN, Zhiwei; ZHANG, Linqi; HO, David, D. Publication Number: WO2006079290 Publication date: 08/03/2006 Kind: Patent Application Publication Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data
    [Show full text]
  • The Potential Role of Extracorporeal Membrane Oxygenation
    Opinion Preparing for the Most Critically Ill Patients With COVID-19 VIEWPOINT The Potential Role of Extracorporeal Membrane Oxygenation Graeme MacLaren, The novel coronavirus has now infected tens of thou- greater. To address this, prompt mobilization of exist- MSc sands of people in China and has spread rapidly around ing registries and clinical research groups should help fa- Cardiothoracic the globe.1 The World Health Organization (WHO) cilitate the systematic collection of data. For example, Intensive Care Unit, has declared the disease, coronavirus disease 2019 the Extracorporeal Life Support Organization (ELSO) National University Health System, (COVID-19), a Public Health Emergency of International Registry is being adapted to acquire new information Singapore. Concern and released interim guidelines on patient about COVID-19 and prospective observational studies management.2 Early reports that emerged from Wuhan, are under way. Dale Fisher, MBBS the epicenter of the outbreak, demonstrated that the ECMO does not provide direct support for organs Division of Infectious clinical manifestations of infection were fever, cough, other than the lungs or heart beyond increasing Diseases, University Medicine Cluster, and dyspnea, with radiological evidence of viral systemic oxygen delivery and mitigating ventilator- National University pneumonia.3,4 Approximately 15% to 30% of these pa- induced lung injury. A substantial proportion of criti- Health Systems, tients developed acute respiratory distress syndrome cally ill patients with COVID-19 appear to have devel- Singapore; and 3 Department of (ARDS). The WHO interim guidelines made general rec- oped cardiac arrhythmias or shock, but it is unknown Medicine, Yong Loo Lin ommendations for treatment of ARDS in this setting, in- how many have or will develop refractory multiorgan School of Medicine, cluding that consideration be given to referring pa- failure, for which ECMO may be of more limited use.
    [Show full text]
  • 0.3 Reaction 1 Yahya Saed Al-Kahes KSA
    AsC Incheon KOR 1 - 4 September 16th Asian Championships, Munhak Stadium Men 100 m 2 September Wind: -0.3 Reaction 1 Yahya Saed Al-Kahes KSA 19 Feb 86 10.39 0.144 2 Shingo Suetsugu JPN 2 Jun 80 10.42 0.175 3 Khaled Yousef Al-Obaidli QAT 17 Aug 81 10.45 0.149 4 Nobuharu Asahara JPN 21 Jun 72 10.57 0.165 5 Wachara Sondee THA 9 Apr 83 10.61 0.181 6 Anil Kumar IND 28 May 73 10.61 0.211 7 Vitaliy Medvedev KAZ 6 Jan 77 10.67 0.157 Vyacheslav Muravyov KAZ 14 Jul 82 DNS 200 m 4 September Wind: 1.8 1 Hamed Hamadan Al-Bishi KSA 3 Mar 82 20.66 SB 0.173 2 Tatsuro Yoshino JPN 11 Sep 82 20.68 0.214 3 Yang Yaozu CHN 9 Jan 81 20.85 0.184 4 Tang Yik Chun HKG 23 Jun 86 21.01 0.183 5 Prasanna S. Amarasekara SRI 21 Mar 81 21.12 SB 0.246 6 Wang Chengliang CHN 4 Aug 85 21.29 0.243 7 Hamood Abd. Al-Dalhami OMA 7 Nov 71 21.31 SB 0.159 8 Hamoud Abdullah Al-Saad KUW 12 Jan 86 21.40 0.297 400 m 3 September 1 Yuzo Kanemaru JPN 18 Sep 87 46.04 0.345 2 Prasanna S. Amarasekara SRI 21 Mar 81 46.48 0.253 3 Rohan Pradeep Kumara SRI 10 Mar 75 46.52 0.330 4 Hamdan Odha Al-Bishi KSA 5 May 81 46.55 0.303 5 Yuki Yamaguchi JPN 22 Feb 84 46.65 0.271 6 Mohamed Akefian IRI 31 May 84 46.93 0.239 7 Reza Bouazar IRI 22 May 87 47.58 0.416 8 Cho Sung-Kwon KOR 10 Feb 82 47.81 0.232 800 m 4 September 1 Majid Saeed Sultan QAT 3 Nov 86 1:44.27 NR AJR PB 2 Abdulrahman Sulaiman QAT 10 Jan 84 1:44.73 PB 3 Sadjad Moradi IRI 30 Mar 83 1:44.74 NR PB 4 Mohammed Al-Salhi KSA 11 May 86 1:45.78 5 Mohamed Mutlak Al-Azimi KUW 16 Jun 82 1:46.67 SB 6 Adnan Taees Akkar IRQ 24 Mar 80 1:47.09 NR SB 7 Yoshihiro Shimodaira JPN 28 Oct 85 1:49.45 8 Mohamed Othman Shahween KSA 15 Feb 86 1:51.19 1500 m 2 September 1 Ali Abubaker Kamal QAT 8 Nov 83 3:44.24 2 Adnan Taees Akkar IRQ 24 Mar 80 3:44.57 PB 3 Nasser Shams Kareem QAT 30 Jan 86 3:46.09 4 Yasunori Murakami JPN 30 Dec 83 3:46.80 5 Mikhail Kolganov KAZ 9 May 80 3:47.45 6 Chaminda Indika Wijekoon SRI 15 Sep 81 3:48.29 7 Ghamanda Ram IND 1 Jul 84 3:49.62 8 J.M.
    [Show full text]